世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Viscosupplementation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global viscosupplementation market is on the path of robust growth, driven by increasing demand for non-invasive osteoarthritis treatments. According to a newly released analysis by Fairfield M... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global viscosupplementation market is on the path of robust growth, driven by increasing demand for non-invasive osteoarthritis treatments. According to a newly released analysis by Fairfield Market Research, the market is anticipated to reach a valuation of US$ 6.5 Bn by 2025 and is projected to surge to US$ 13.5 Bn by 2032, exhibiting a healthy CAGR of 11.01% during the forecast period of 2022 to 2032.Market Insights Viscosupplementation, a therapeutic technique involving the injection of hyaluronic acid into the joint cavity, has gained significant traction as a minimally invasive treatment for osteoarthritis. With rising awareness of the benefits of non-surgical interventions and the increasing prevalence of musculoskeletal disorders, the market has witnessed a noticeable uptick in adoption. A major trend propelling the market is the clinical validation of viscosupplements as effective pain management solutions, especially for knee osteoarthritis. Products such as Orthovisc, Hyalgan, and Synvisc have received regulatory approvals, reinforcing their credibility and boosting market confidence. Additionally, favorable reimbursement policies in countries like the U.S. and France are strengthening market penetration, particularly among the aging population. Key Drivers of Growth The market is being significantly influenced by several dynamic factors: • Rising global incidence of osteoarthritis and obesity among aging populations. • Growing preference for alternatives to corticosteroid treatments due to side-effect concerns. • Technological advancements in hyaluronic acid-based therapies. • Expansion in FDA approvals for viscosupplement products, especially single and three-injection solutions. • Shorter procedural times and improved patient outcomes driving adoption in outpatient settings. According to the World Health Organization, the aging population globally is set to reach 16% by 2050. This demographic trend correlates strongly with a surge in osteoarthritis diagnoses, thus creating a sustained demand for viscosupplementation therapies. Business Opportunity The increasing adoption of single-injection viscosupplements presents a substantial business opportunity. These products offer benefits such as reduced hospital visits, minimal side effects, and enhanced patient compliance. As regulatory bodies continue to approve newer formulations and as more advanced products hit the market, companies have a chance to capitalize on this growing segment. Anika Therapeutics’ MONOVISC, the first non-animal sourced single-injection solution approved by the FDA, is a testament to how innovation can reshape market dynamics. Moreover, investments in research and development, as seen in Bone Therapeutics’ JTA-004 or Anika’s Hyalofast, signal future expansion into cartilage repair and regenerative therapies. Regional Analysis Asia Pacific is emerging as the most promising regional market, expected to witness the highest growth rate during the forecast period. Key factors include a rapidly aging population, increasing awareness about osteoarthritis treatments, and expanding healthcare infrastructure in countries like India and China. The region’s cost-effectiveness and growing medical tourism industry further attract investments. The United States remains a dominant force in the global market due to its robust healthcare system, high prevalence of osteoarthritis, and strong inclination toward advanced therapeutic options. European nations like the UK and France are also notable contributors, owing to government reimbursement policies and rising geriatric populations. Japan and South Korea are exhibiting accelerating growth trends due to continuous product innovations and improved access to orthopedic care, positioning them as high-growth territories within the broader Asia Pacific region. Key Players The viscosupplementation market is characterized by strong competition and innovation, with key players focusing on product development and strategic partnerships to strengthen their market presence. Leading companies include: • Sanofi • Anika Therapeutics, Inc. • Seikagaku Corp. • Zimmer Biomet • Smith & Nephew PLC • Ferring Pharmaceuticals B.V. • Lifecore Biomedical • LG Life Sciences Ltd. • Fidia Farmaceutici S.p.A • F. Hoffmann-La Roche Ltd. Recent developments include Bioventus receiving FDA approval for DUROLANE, a single-injection viscosupplement, and Anika Therapeutics introducing Hyalofast at an international medical congress. These developments are poised to enhance the therapeutic Analysis for patients suffering from degenerative joint conditions. Market Segmentation By Product Type • Single Injection • Three Injection • Five Injection By End User • Hospitals • Orthopaedic Clinics / Ambulatory Surgical Centres (ASCs) Table of Contents1. Executive Summary1.1. Global Viscosupplementation Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Viscosupplementation Market Outlook, 2019-2032 3.1. Global Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 3.1.1. Key Highlights 3.1.1.1. Single Injection 3.1.1.2. Three Injection 3.1.1.3. Five Injection 3.2. Global Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Hospitals 3.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 3.3. Global Viscosupplementation Market Outlook, by Region, Value (US$ Bn), 2019-2032 3.3.1. Key Highlights 3.3.1.1. North America 3.3.1.2. Europe 3.3.1.3. Asia Pacific 3.3.1.4. Latin America 3.3.1.5. Middle East & Africa 4. North America Viscosupplementation Market Outlook, 2019-2032 4.1. North America Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 4.1.1. Key Highlights 4.1.1.1. Single Injection 4.1.1.2. Three Injection 4.1.1.3. Five Injection 4.2. North America Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Hospitals 4.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 4.2.2. BPS Analysis/Market Attractiveness Analysis 4.3. North America Viscosupplementation Market Outlook, by Country, Value (US$ Bn), 2019-2032 4.3.1. Key Highlights 4.3.1.1. U.S. Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 4.3.1.2. U.S. Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 4.3.1.3. Canada Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 4.3.1.4. Canada Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 4.3.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Viscosupplementation Market Outlook, 2019-2032 5.1. Europe Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 5.1.1. Key Highlights 5.1.1.1. Single Injection 5.1.1.2. Three Injection 5.1.1.3. Five Injection 5.2. Europe Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Hospitals 5.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 5.2.2. BPS Analysis/Market Attractiveness Analysis 5.3. Europe Viscosupplementation Market Outlook, by Country, Value (US$ Bn), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Germany Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.2. Germany Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.3. U.K. Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.4. U.K. Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.5. France Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.6. France Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.7. Italy Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.8. Italy Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.9. Turkey Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.10. Turkey Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.11. Russia Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.12. Russia Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.1.13. Rest of Europe Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 5.3.1.14. Rest of Europe Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 5.3.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Viscosupplementation Market Outlook, 2019-2032 6.1. Asia Pacific Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 6.1.1. Key Highlights 6.1.1.1. Single Injection 6.1.1.2. Three Injection 6.1.1.3. Five Injection 6.2. Asia Pacific Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Hospitals 6.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 6.2.2. Others BPS Analysis/Market Attractiveness Analysis 6.3. Asia Pacific Viscosupplementation Market Outlook, by Country, Value (US$ Bn), 2019-2032 6.3.1. Key Highlights 6.3.1.1. China Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.2. China Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.1.3. Japan Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.4. Japan Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.1.5. South Korea Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.6. South Korea Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.1.7. India Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.8. India Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.1.9. Southeast Asia Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.10. Southeast Asia Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.1.11. Rest of Asia Pacific Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 6.3.1.12. Rest of Asia Pacific Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 6.3.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Viscosupplementation Market Outlook, 2019-2032 7.1. Latin America Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 7.1.1. Key Highlights 7.1.1.1. Single Injection 7.1.1.2. Three Injection 7.1.1.3. Five Injection 7.2. Latin America Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 7.2.1.1. Hospitals 7.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 7.2.2. BPS Analysis/Market Attractiveness Analysis 7.3. Latin America Viscosupplementation Market Outlook, by Country, Value (US$ Bn), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Brazil Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 7.3.1.2. Brazil Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 7.3.1.3. Mexico Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 7.3.1.4. Mexico Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 7.3.1.5. Argentina Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 7.3.1.6. Argentina Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 7.3.1.7. Rest of Latin America Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 7.3.1.8. Rest of Latin America Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 7.3.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Viscosupplementation Market Outlook, 2019-2032 8.1. Middle East & Africa Viscosupplementation Market Outlook, by Product Type, Value (US$ Bn), 2019-2032 8.1.1. Key Highlights 8.1.1.1. Single Injection 8.1.1.2. Three Injection 8.1.1.3. Five Injection 8.2. Middle East & Africa Viscosupplementation Market Outlook, by End User, Value (US$ Bn), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Hospitals 8.2.1.2. Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs) 8.2.2. BPS Analysis/Market Attractiveness Analysis 8.3. Middle East & Africa Viscosupplementation Market Outlook, by Country, Value (US$ Bn), 2019-2032 8.3.1. Key Highlights 8.3.1.1. GCC Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 8.3.1.2. GCC Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 8.3.1.3. South Africa Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 8.3.1.4. South Africa Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 8.3.1.5. Egypt Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 8.3.1.6. Egypt Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 8.3.1.7. Nigeria Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 8.3.1.8. Nigeria Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 8.3.1.9. Rest of Middle East & Africa Viscosupplementation Market by Product Type, Value (US$ Bn), 2019-2032 8.3.1.10. Rest of Middle East & Africa Viscosupplementation Market by End User, Value (US$ Bn), 2019-2032 8.3.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Manufacturer vs by End User Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Sanofi 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Development 9.4.2. Anika Therapeutics, Inc. 9.4.2.1. Company Overview 9.4.2.2. Product Portfolio 9.4.2.3. Financial Overview 9.4.2.4. Business Strategies and Development 9.4.3. Seikagaku Corp. 9.4.3.1. Company Overview 9.4.3.2. Product Portfolio 9.4.3.3. Financial Overview 9.4.3.4. Business Strategies and Development 9.4.4. Zimmer Biomet 9.4.4.1. Company Overview 9.4.4.2. Product Portfolio 9.4.4.3. Financial Overview 9.4.4.4. Business Strategies and Development 9.4.5. Smith & Nephew PLC 9.4.5.1. Company Overview 9.4.5.2. Product Portfolio 9.4.5.3. Financial Overview 9.4.5.4. Business Strategies and Development 9.4.6. Ferring Pharmaceuticals B.V. 9.4.6.1. Company Overview 9.4.6.2. Product Portfolio 9.4.6.3. Financial Overview 9.4.6.4. Business Strategies and Development 9.4.7. Lifecore Biomedical 9.4.7.1. Company Overview 9.4.7.2. Product Portfolio 9.4.7.3. Financial Overview 9.4.7.4. Business Strategies and Development 9.4.8. LG Life Sciences Ltd. 9.4.8.1. Company Overview 9.4.8.2. Product Portfolio 9.4.8.3. Financial Overview 9.4.8.4. Business Strategies and Development 9.4.9. Fidia Farmaceutici S.p.A 9.4.9.1. Company Overview 9.4.9.2. Product Portfolio 9.4.9.3. Financial Overview 9.4.9.4. Business Strategies and Development 9.4.10. F.Hoffmann-La Roche Ltd. 9.4.10.1. Company Overview 9.4.10.2. Product Portfolio 9.4.10.3. Financial Overview 9.4.10.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の医薬品・バイオテクノロジー分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
